SAVIENT PHARMACEUTICALS INC·4

Feb 25, 4:35 PM ET

FERRARI LOUIS 4

4 · SAVIENT PHARMACEUTICALS INC · Filed Feb 25, 2013

Insider Transaction Report

Form 4
Period: 2013-02-25
FERRARI LOUIS
SVP, North American Commerical
Transactions
  • Sale

    Common Stock $.01 par value per share

    2013-02-25$0.99/sh375$371295,996 total
Footnotes (1)
  • [F1]These shares were sold automatically pursuant to a binding contract under Rule 10b5-1 of the Securities Exchange Act of 1934 to cover tax withholding obligations in connection with the vesting of restricted stock granted on February 21, 2011.

Documents

1 file
  • 4
    rrd371802.xmlPrimary

    FERRARI FORM 4